Mojca Matičič
YOU?
Author Swipe
European Code Against Cancer, 5th edition – cancer‐causing infections and related interventions Open
The main infections that cause cancer in the European Union (EU) are Helicobacter pylori ( H. pylori ), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Altogether, in 202…
Liraglutide Treatment Restores Cardiac Function After Isoprenaline-Induced Myocardial Injury and Prevents Heart Failure in Rats Open
Background: Myocardial injury (MI) is characterized by an increased level of at least one cardiac troponin. Experimental MI can be induced by isoprenaline, a β-adrenergic agonist, and it can lead to heart failure (HF). Liraglutide is gluca…
View article: Ursodeoxycholic and chenodeoxycholic bile acids alleviate endotoxininduced acute lung injury in rats by modulating aquaporin expression and pathways associated with apoptosis and inflammation
Ursodeoxycholic and chenodeoxycholic bile acids alleviate endotoxininduced acute lung injury in rats by modulating aquaporin expression and pathways associated with apoptosis and inflammation Open
Introduction This study aimed to investigate the anti-inflammatory, antioxidant, and anti-apoptotic properties of ursodeoxycholic (UDCA) and chenodeoxycholic (CDCA) bile acids in a rat model of endotoxin (lipopolysaccharide, LPS)-induced a…
Public health and clinical response to an mpox outbreak in Slovenia: case study, 2022–2023 Open
Objectives The emergence of mpox outbreaks in non-endemic areas, characterised by human-to-human transmission and unique clinical presentations, poses challenges in containment efforts. This study aimed to analyse the 2022 outbreak in Slov…
Prophylactic Treatment of Hepatitis C Virus Infection After Kidney Transplantation with the Combination of Glecaprevir/Pibrentasvir and Sofosbuvir in a Highly Sensitized Hepatitis C Virus-Negative Recipient: A Case Report and Review of the Literature Open
Background: Since the discovery of successful direct-acting antiviral (DAA) treatment, kidneys from hepatitis C virus (HCV) RNA-positive donors represent a new opportunity to expand the organ donor pool for HCV-negative recipients. Case pr…
Metagenomic Sequencing for Diagnosing Listeria-Induced Rhombencephalitis in Patient and Contaminated Cheese Samples: A Case Report Open
Among the various causes of rhomboencephalitis, Listeria monocytogenes infection is the most common. However, conventional microbiological methods often yield negative results, making diagnosis challenging and leading to extensive, often i…
Phylodynamic inference suggests introductions as main driver of Mpox Clade II outbreak in 2022 in Slovenia Open
In 2022, an Mpox clade II outbreak affected many countries. To optimize control, knowledge on the number of new introductions (human cases infected from outside the study population) versus local transmission is important. We extracted seq…
View article: Towards eliminating hepatitis C as a public health threat: different speeds, different needs
Towards eliminating hepatitis C as a public health threat: different speeds, different needs Open
Preview this article: Towards eliminating hepatitis C as a public health threat: different speeds, different needs, Page 1 of 1 /docserver/preview/fulltext/eurosurveillance/29/30/eurosurv-29-30-1-1.gif
Correction: Monitoring progress towards elimination of hepatitis B and C in the EU/EEA Open
[This corrects the article DOI: 10.1371/journal.pgph.0000841.].
View article: Acute severe hepatitis outbreak in children: A perfect storm. What do we know, and what questions remain?
Acute severe hepatitis outbreak in children: A perfect storm. What do we know, and what questions remain? Open
During the first half of 2022, the World Health Organization reported an outbreak of acute severe hepatitis of unknown aetiology (AS-Hep-UA) in children, following initial alerts from the United Kingdom (UK) where a cluster of cases was fi…
View article: Securing wider EU commitment to the elimination of hepatitis C virus
Securing wider EU commitment to the elimination of hepatitis C virus Open
In 2016, the Hepatitis B and C Public Policy Association (HepBCPPA), gathered all the main stakeholders in the field of hepatitis C virus (HCV) to launch the now landmark HCV Elimination Manifesto, calling for the elimination of HCV in the…
Monitoring progress towards elimination of hepatitis B and C in the EU/EEA Open
This paper presents data on selected indicators to show progress towards elimination goals and targets for hepatitis B and hepatitis C in the 31 countries of the European Union (EU) and European Economic Area (EEA). A monitoring system was…
Hepatitis B elimination in children of Slovenian origin born in Slovenia after the introduction of preventive strategies: The results of a national study Open
Introduction In Slovenia national strategies to prevent hepatitis B virus (HBV) infection in children were introduced in the mid-nineties. The aim of the present study was to analyze the epidemiological characteristics of chronic hepatitis…
Vaccination in the Yugoslav National Army: A Significant Risk Factor for Acquiring Chronic Hepatitis B Virus Infection During Army Service in the Former Yugoslavia Open
Background: To prevent the spread of infectious diseases, several state armies implemented obligatory vaccination programs also practiced in the former Yugoslav National Army (YNA). Iatrogenic hepatitis B virus (HBV) transmissions during v…
A centralised novel coronavirus telephone helpline: a tool for managing and tracking the nation’s response to the COVID-19 epidemic in Slovenia Open
In response to neighbouring Italy’s accelerating outbreak of the coronavirus disease 2019 (COVID-19), Slovenia established a national toll-free telephone helpline, which operated from 9 March until 12 June 2020 and answered more than 40 th…
The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries Open
Background People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DA…
Civil Society Monitoring of Hepatitis C Response Related to the WHO 2030 Elimination Goals in 35 European Countries Open
BackgroundPeople who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe, however HCV testing and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs)…
The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data Open
Patient groups reported that the European region is not on track to meet WHO 2030 HCV goals. More action should be taken to implement and monitor HCV policies.
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper Open
The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to healthcare systems in affected communities. Older patients and those with pre-existing medical conditions have been identified as populations at risk of a seve…